(Q39785801)

14 September 2017

title

Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia (English)

1 reference

14 September 2017

1 reference

10

Kjeld Schmiegelow

1 reference

14 September 2017

6

Henrik Hasle

1 reference

14 September 2017

4

Jukka Kanerva

1 reference

14 September 2017

Bendik Lund

1

1 reference

14 September 2017

Ann Åsberg

2

1 reference

14 September 2017

Mats Heyman

3

1 reference

14 September 2017

Arja Harila-Saari

5

1 reference

14 September 2017

Stefan Söderhäll

7

1 reference

14 September 2017

Ólafur Gisli Jónsson

8

1 reference

14 September 2017

Stian Lydersen

9

1 reference

14 September 2017

Nordic Society of Paediatric Haematology and Oncology

11

1 reference

14 September 2017

publication date

8 December 2010

1 reference

14 September 2017

published in

Pediatric Blood & Cancer

1 reference

14 September 2017

volume

56

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

551-559

1 reference

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

14 September 2017

cites work

1 reference

Treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

Treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.

21 January 2018

1 reference

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

21 January 2018

1 reference

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

21 January 2018

1 reference

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

21 January 2018

1 reference

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

21 January 2018

1 reference

21 January 2018

1 reference

Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study

21 January 2018

1 reference

Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

21 January 2018

1 reference

Non-Hodgkin's lymphoma in children.A progress report on the original patients treated with the LSA2-L2 protocol

21 January 2018

1 reference

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).

21 January 2018

1 reference

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review

21 January 2018

1 reference

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients

21 January 2018

1 reference

Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres

21 January 2018

1 reference

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

21 January 2018

1 reference

Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials

21 January 2018

1 reference

Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma

21 January 2018

1 reference

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

21 January 2018

1 reference

Fungal infections in leukemia patients: how do we prevent and treat them?

21 January 2018

1 reference

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation

21 January 2018

1 reference

Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis

21 January 2018

1 reference

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

21 January 2018

1 reference

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.22719

1 reference

release_mpkm3ranqzhb5dzrednmo6vsoq

14 September 2017

Fatcat ID

0 references

1 reference